TrialThe Journal of dermatology2021

Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double-blind, placebo-controlled study.

Seong Jun Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.